Private Wealth Asset Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
Private Wealth Asset Management's PBYI Position: Q3 2026 in Review
Private Wealth Asset Management sold out of Puma Biotechnology (PBYI) in Q3 2026, closing a stake of 3,500 shares — an estimated $28.4K sold.
Private Wealth Asset Management first reported a position in PBYI in Q1 2025 and held it in 6 quarters. The position peaked at $28.4K in Q2 2026. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- Private Wealth Asset Management reported no remaining Puma Biotechnology position as of Q3 2026 after selling out during the quarter.
- Private Wealth Asset Management sold 3,500 Puma Biotechnology shares in Q3 2026, an estimated $28.4K.
- Private Wealth Asset Management first reported a position in Puma Biotechnology in Q1 2025 and held it in 6 quarters.
- Private Wealth Asset Management's Puma Biotechnology position peaked at $28.4K in Q2 2026.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on Private Wealth Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.